Elizabeth Sirban
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $107.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- Abbott$654
- Novo Nordisk$319
- Teva Pharmaceuticals USA, Inc.$306
- Abiomed$291
- Neurocrine Biosciences, Inc.$241
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,825100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $727 |
| Abbott | 5 | $654 |
| Novo Nordisk | 3 | $319 |
| Teva Pharmaceuticals USA, Inc. | 3 | $306 |
| Abiomed | 3 | $291 |
| Neurocrine Biosciences, Inc. | 2 | $241 |
| Actelion Pharmaceuticals US, Inc. | 2 | $241 |
| Amgen | 2 | $229 |
| Insmed, Inc. | 2 | $195 |
| Dexcom, Inc. | 1 | $142 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $122 |
| AstraZeneca | 1 | $121 |
| Axonics, Inc. | 2 | $118 |
| Argenx US, Inc. | 1 | $116 |
| Alkermes, Inc. | 1 | $115 |
| Boston Scientific | 1 | $105 |
| Boehringer Ingelheim | 1 | $101 |
| Sanofi | 1 | $93 |
| Arcutis Biotherapeutics, Inc. | 1 | $90 |
| Bayer | 1 | $85 |
| Sanofi Pasteur Inc. | 1 | $84 |
| Genentech USA, Inc. | 1 | $80 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$459
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$295
- INGREZZA$241
- UPTRAVI$241
- OPSUMIT$241
- VRAYLAR$240
- Wegovy$203
- DEXCOM G7 GSS (161)$142
- FREESTYLE LIBRE 3$125
- NEXLIZET$125
- NEXLETOL$125
- REXULTI$125
- KRYSTEXXA$124
- TZIELD$122
- AIRSUPRA$121
- AJOVY$121
- CARDIOMEMS$121
- VYVGART$116
- Ozempic$116
- MitraClip$112
How this compares
$4,825 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 12 | $274 |
Paid to pharmacies, not to this prescriber.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- Rasheeta ChandlerTampa$37K
- Rosaly TorresTampa$28K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.